Brokerages Set U.S. Physical Therapy, Inc. (NYSE:USPH) Price Target at $105.33

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have been assigned a consensus rating of “Moderate Buy” from the seven research firms that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $105.3333.

A number of research analysts have issued reports on USPH shares. Barrington Research reaffirmed an “outperform” rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a report on Monday, January 5th. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. JPMorgan Chase & Co. reduced their price objective on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Monday, November 24th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st.

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock opened at $82.40 on Thursday. The company has a market cap of $1.25 billion, a P/E ratio of 34.62, a price-to-earnings-growth ratio of 3.42 and a beta of 1.29. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $93.50. The business has a fifty day moving average of $79.81 and a two-hundred day moving average of $81.20. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.20 and a current ratio of 1.20.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.01). U.S. Physical Therapy had a return on equity of 8.62% and a net margin of 5.71%.The company had revenue of $197.13 million for the quarter, compared to analyst estimates of $193.98 million. During the same period last year, the company earned $0.69 earnings per share. The business’s revenue for the quarter was up 17.3% compared to the same quarter last year. As a group, analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Investors of record on Monday, November 17th were paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Monday, November 17th. U.S. Physical Therapy’s dividend payout ratio is presently 75.63%.

Institutional Trading of U.S. Physical Therapy

Several institutional investors and hedge funds have recently modified their holdings of USPH. Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy by 8.9% in the second quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock valued at $69,499,000 after purchasing an additional 72,463 shares during the last quarter. Bahl & Gaynor Inc. lifted its stake in U.S. Physical Therapy by 47.6% in the 3rd quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock valued at $40,325,000 after buying an additional 153,054 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in U.S. Physical Therapy by 6.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 474,244 shares of the company’s stock valued at $40,285,000 after buying an additional 27,577 shares during the last quarter. Geode Capital Management LLC increased its position in U.S. Physical Therapy by 1.2% during the second quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock worth $27,602,000 after buying an additional 4,306 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its holdings in shares of U.S. Physical Therapy by 9.4% in the second quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company’s stock worth $27,070,000 after acquiring an additional 29,671 shares during the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.